Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Government Faces Setback In Pledged $124 Billion In Funding For Health System Reforms

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The Chinese government's sweeping health system reforms, set to be launched in stages over the next decade, are facing significant funding setbacks, according to an analyst who has been closely monitoring the process

You may also be interested in...



New Chinese Finance Ministry Funding For Healthcare Reforms Reflects Boost Slated For 2011

SHANGHAI - One week after China's Ministry Of Health unveiled its new five year plan for reforms in public hospitals, the Ministry Of Finance announced Nov. 18 that the central government has allocated RMB 12.3 billion ($1.85 billion) to support local healthcare reforms

New Chinese Finance Ministry Funding For Healthcare Reforms Reflects Boost Slated For 2011

SHANGHAI - One week after China's Ministry Of Health unveiled its new five year plan for reforms in public hospitals, the Ministry Of Finance announced Nov. 18 that the central government has allocated RMB 12.3 billion ($1.85 billion) to support local healthcare reforms

Will China Healthcare Reform Drive Higher Rewards For Innovative Drugs?

BEIJING - China's sweeping healthcare reforms - designed to provide universal coverage for more than 1.3 billion citizens and build or upgrade medical care facilities across the country - are likely to have staggered benefits on varying industries over the next decade

Related Content

Latest News
UsernamePublicRestriction

Register

SC074638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel